Target intelligence / Profile preview

Ras-interacting protein 1 (RASIP1)

Target
RASIP1
Molecular classification
Other (Endothelial Ras/Rap effector protein), Adapter protein (effector of small GTPases; contains a Ras-association domain)
01

Overview

Ras-interacting protein 1 (RASIP1) is an adapter protein predominantly expressed in endothelial cells, where it functions as an effector for small GTPases such as Rap1 and Ras[2][5]. RASIP1 is essential for vascular development, mediating vasculogenesis and angiogenesis by regulating cytoskeletal organization, cell adhesion, and endothelial cell junction integrity[1][4][5]. Mechanistically, RASIP1 interacts with Rap1 and suppresses RhoA/ROCK signaling through recruitment of ARHGAP29, enabling proper cell spreading and maintaining vascular barrier function[1][3][4]. RASIP1 also binds directly to the cytoplasmic domain of the transmembrane protein Heart of Glass (HEG1), anchoring it to endothelial cell-cell junctions[4]. Knockdown or genetic deletion of RASIP1 leads to profound defects in blood vessel formation and vascular collapse[4][5], and genetic variants in RASIP1 have recently been associated with late-onset Alzheimer's disease risk[3]. No drugs are known to target RASIP1 directly, but its central role in vascular health makes it a potential therapeutic target for cardiovascular and inflammatory diseases, with notable risks if inhibited due to its essential role in endothelial function[4][5].

Other names
RASIP1Rainras-interacting protein 1FLJ20401RAIN
02

Mechanism of action

Adapter/linker for small GTPases (Rap1 and Ras), modulating RhoA and ROCK signaling. It interacts with ARHGAP29 to suppress RhoA signaling. RASIP1 maintains vascular integrity via cytoskeletal dynamics and cell junctions.

03

Biological functions

Regulation of GTPase signalingEndothelial cell morphogenesisBlood vessel tubulogenesisVascular development (vasculogenesis and angiogenesis)Cell–cell and cell–matrix adhesionRegulation of cytoskeletal rearrangement and cell architectureJunctional tightening and endothelial barrier functionInhibition of RhoA/ROCK signaling
04

Disease associations

Cardiovascular disease (deficiency leads to vascular collapse)Neurodegenerative disease (associated with Alzheimer's disease risk in GWAS)
05

Safety considerations

Null phenotype is embryonically lethal in mice, indicating that inhibition may pose serious cardiovascular risksCritical for endothelial cell structure—loss leads to vascular collapse

Beyond the preview

Go deeper on Ras-interacting protein 1 (RASIP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-interacting protein 1 (RASIP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call